Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment

Expert Review of Cardiovascular Therapy
Carmine Gazzaruso

Abstract

The current review reports recent data available in the literature on the prevalence of erectile dysfunction and the association of erectile dysfunction with overt and silent coronary artery disease in patients with diabetes mellitus. The mechanisms by which erectile dysfunction is associated with coronary artery disease and potential clinical implications of this association have been extensively analysed. In particular, the role of endothelial dysfunction in the pathophysiology of erectile dysfunction and the potential clinical usefulness of erectile dysfunction to identify diabetic patients with silent coronary artery disease have been outlined. Finally, recent guidelines on the treatment of erectile dysfunction with phosphodiesterase-5 inhibitors in diabetic patients with and without coronary artery disease have been reported and discussed.

References

Oct 7, 1997·International Journal of Impotence Research·A GreensteinZ Braf
Oct 23, 1997·The Journal of Urology·S FrancavillaA Santucci
Jun 5, 1999·International Journal of Impotence Research·M J Metro, G A Broderick
Feb 25, 2000·The Journal of Urology·J H RomeoD C Aron
Jun 1, 2000·The New England Journal of Medicine·H C HerrmannP D Mahoney
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jun 27, 2001·International Journal of Impotence Research·Y KawanishiT Sogou
Feb 20, 2002·JAMA : the Journal of the American Medical Association·Adelaide M Arruda-OlsonPatricia A Pellikka
Jun 22, 2002·Archives of Internal Medicine·Howard A FinkTimothy J Wilt
Jul 12, 2002·Diabetes/metabolism Research and Reviews·Euan A AshleyVictor Froelicher
Oct 18, 2002·Journal of the American College of Cardiology·Julian P J HalcoxArshed A Quyyumi
Dec 4, 2002·The Journal of Clinical Hypertension·Carlos M Ferrario, Pavel Levy
Jan 11, 2003·The American Journal of Cardiology·Hemant SolomonGraham Jackson
Mar 20, 2003·Current Diabetes Reports·Donald Richardson, Aaron Vinik
Apr 30, 2003·Diabetes Care·Aaron I VinikRoy Freeman
Jul 11, 2003·The Journal of Urology·Robert A KlonerHarin Padma-Nathan
Aug 22, 2003·BJU International·H A FinkT J Wilt
Aug 23, 2003·European Urology·Piero MontorsiClaude C Schulman
Nov 12, 2003·The American Journal of Cardiology·Robert A KlonerJeffrey T Emmick
Dec 9, 2003·European Heart Journal·Kim M FoxUNKNOWN CAESAR I (Clinical American and European Studies of Angina and Revascularization) investigators
Jan 13, 2004·The American Journal of Cardiology·Robert F DeBuskMichael Sweeney
Feb 27, 2004·International Journal of Impotence Research·W A BlumentalsV Vannappagari
May 6, 2004·Vascular Medicine·Charalambos VlachopoulosMichael F O'Rourke
Jun 5, 2004·American Journal of Hypertension·JorgeEduardo ToblliFelipe Inserra
Jun 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Trinity J BivalacquaPhilip J Kadowitz
Jun 24, 2004·JAMA : the Journal of the American Medical Association·Katherine EspositoDario Giugliano
Jul 31, 2004·Journal of the American Society of Nephrology : JASN·Dierk H Endemann, Ernesto L Schiffrin
Aug 11, 2004·International Journal of Cardiology·Hemant Solomon, Robert F DeBusk
Aug 21, 2004·Preventive Cardiology·Melvin D Cheitlin
Apr 28, 2005·International Journal of Clinical Practice·M KirbyU Simonsen
Apr 28, 2005·Diabetes Care·Katherine EspositoDario Giugliano
Jul 7, 2005·European Urology·Anton PonholzerStephan Madersbacher

❮ Previous
Next ❯

Citations

Aug 7, 2008·International Urology and Nephrology·Kosmas I ParaskevasVassilios Andrikopoulos
Oct 21, 2006·International Journal of Impotence Research·J Y JeremyN Shukla
Nov 15, 2011·Drug Development and Industrial Pharmacy·Ming Ming WenSaid A Khalil
May 16, 2014·Canadian Journal of Diabetes·Gerald BrockWilliam Harper
Jul 9, 2009·BJU International·Roger Kirby, Mike Kirby

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
Ian M ThompsonCharles A Coltman
Current Pharmaceutical Design
Thorsten Reffelmann, Robert A Kloner
© 2021 Meta ULC. All rights reserved